Ceregene Scientific Co-Founder Publishes Alzheimer's Disease Clinical Trial Results in Nature Medicine
27-Apr-2005 -
Ceregene, Inc. scientific co- founder, Mark Tuszynski M.D., Ph.D., published in the online edition of Nature Medicine (May 2005) the results of the first ever Phase I clinical study for the treatment of Alzheimer's disease using gene therapy. Ceregene, Inc. has licensed the technology and product ...
absorption
Alzheimer's disease
BrainCells
+9